BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34099039)

  • 1. Diagnosis and clinical management of canine leishmaniosis by general veterinary practitioners: a questionnaire-based survey in Portugal.
    Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
    Parasit Vectors; 2021 Jun; 14(1):306. PubMed ID: 34099039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dogs with leishmaniosis: how are we managing proteinuria in daily practice? A Portuguese questionnaire-based study.
    Monteiro M; Prata S; Cardoso L; Pereira da Fonseca I; Leal RO
    Parasit Vectors; 2022 Apr; 15(1):125. PubMed ID: 35410442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest trends in L. infantum infection in dogs in Spain, Part II: current clinical management and control according to a national survey of veterinary practitioners.
    Montoya A; Gálvez R; Checa R; Sarquis J; Plaza A; Barrera JP; Marino V; Miró G
    Parasit Vectors; 2020 Apr; 13(1):205. PubMed ID: 32317018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dialysis and long-term treatment of a dog with kidney disease associated with canine leishmaniosis.
    Baneth G; Segev G; Mazaki-Tovi M; Chen H; Kuzi S
    Parasit Vectors; 2018 Mar; 11(1):151. PubMed ID: 29554974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis.
    Solano-Gallego L; Koutinas A; Miró G; Cardoso L; Pennisi MG; Ferrer L; Bourdeau P; Oliva G; Baneth G
    Vet Parasitol; 2009 Oct; 165(1-2):1-18. PubMed ID: 19559536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020).
    Olías-Molero AI; Fontán-Matilla E; Cuquerella M; Alunda JM
    Parasit Vectors; 2021 Jan; 14(1):36. PubMed ID: 33422141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency and distribution of canine leishmaniosis diagnosed by veterinary practitioners in Europe.
    Mattin MJ; Solano-Gallego L; Dhollander S; Afonso A; Brodbelt DC
    Vet J; 2014 Jun; 200(3):410-9. PubMed ID: 24767097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, blinded, controlled clinical trial comparing the efficacy of aminosidine (paromomycin)-allopurinol combination with the efficacy of meglumine antimoniate-allopurinol combination for the treatment of canine leishmaniosis due to Leishmania infantum.
    Kasabalis D; Chatzis MK; Apostolidis K; Petanides T; Athanasiou LV; Xenoulis PG; Mataragka A; Ikonomopoulos J; Leontides LS; Saridomichelakis MN
    Exp Parasitol; 2020 Jul; 214():107903. PubMed ID: 32360142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
    Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
    Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R
    Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey on canine leishmaniosis: Best practice and guideline awareness among Italian veterinary practitioners.
    Vismarra A; Kramer LH; Moschi A; Ciuca L; Genchi M
    Prev Vet Med; 2021 Oct; 195():105450. PubMed ID: 34364152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management, prevention and treatment of canine leishmaniosis in north-eastern Spain: an online questionnaire-based survey in the province of Girona with special emphasis on new preventive methods (CaniLeish vaccine and domperidone).
    Lladró S; Picado A; Ballart C; Portús M; Gállego M
    Vet Rec; 2017 Jan; 180(2):47. PubMed ID: 27895289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment.
    Santos MF; Alexandre-Pires G; Pereira MA; Marques CS; Gomes J; Correia J; Duarte A; Gomes L; Rodrigues AV; Basso A; Reisinho A; Meireles J; Santos-Mateus D; Brito MTV; Tavares L; Santos-Gomes GM; da Fonseca IP
    Front Vet Sci; 2019; 6():362. PubMed ID: 31681815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey.
    Bourdeau P; Saridomichelakis MN; Oliveira A; Oliva G; Kotnik T; Gálvez R; Foglia Manzillo V; Koutinas AF; Pereira da Fonseca I; Miró G
    Parasit Vectors; 2014 Mar; 7():110. PubMed ID: 24656172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
    de Jong MK; Rappoldt A; Broere F; Piek CJ
    Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
    Miró G; Oliva G; Cruz I; Cañavate C; Mortarino M; Vischer C; Bianciardi P
    Vet Dermatol; 2009 Oct; 20(5-6):397-404. PubMed ID: 20178476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.